The landscape of dementia analysis has advanced considerably with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent tests that could detect Alzheimer's pathology decades prior to signs or symptoms arise. Whilst these technological improvements characterize outstanding progress in knowledge neurodeg